Concepedia
Statistics
Publications
2
Citations
725
H-Index
Active since
2009
Affiliations
Bristol-Myers Squibb (United States)(Current)
L Li is an author at Bristol-Myers Squibb (United States).
Publications per year
2009–2009
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus
Bernard J. Komoroski, N. Vachharajani, L Li et al. · Clinical Pharmacology & Therapeutics · 2009 · 383 citations
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
Bernard J. Komoroski, N. Vachharajani, David W. Boulton et al. · Clinical Pharmacology & Therapeutics · 2009 · 342 citations
1–2 of 2